List of works by Peter Irving

"Diversion" colitis caused by Clostridium difficile infection: report of a case

scientific article published on 01 July 2006

732 Laboratory Parameters Related to Monitoring in Patients With Ulcerative Colitis Treated With Tofacitinib for up to 3 Years in the OCTAVE Open-Label, Long-Term Extension Study ⬇️

scholarly article

829 Appropriateness of Treatment Options in Mild to Moderate Ulcerative Colitis: A RAND Appropriateness Panel ⬇️

scholarly article

902 - Low Fodmap Diet Improves Functional-Like Gastrointestinal Symptoms but Reduces Bifidobacteria and Faecalibacterium Prausnitzii in Quiescent Inflammatory Bowel Disease: A Randomised Controlled Trial and Metagenomic Analysis

scholarly article published in May 2018

A Biochemical Mechanism for the Role of Allopurinol in TPMT Inhibition

scholarly article published in May 2011

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis

scientific article published on 01 March 2018

A practical guide to thiopurine prescribing and monitoring in IBD

scientific article published on 29 August 2016

A retrospective observational study of early experiences of vedolizumab treatment for inflammatory bowel disease in the UK: The REVIVE study

scientific article published on 01 March 2019

Acute mesenteric infarction: an important cause of abdominal pain in ulcerative colitis

scientific article published on 01 December 2005

Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel

scientific article published on 08 June 2020

Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel

scientific article published on 01 September 2020

Alopecia areata: a possible extraintestinal manifestation of Crohn's disease

scientific article published on 03 June 2013

Anti-TNF drug and antidrug antibody level monitoring in IBD: a practical guide

scientific article published on 21 January 2015

Anti-infliximab antibodies in inflammatory bowel disease: prevalence, infusion reactions, immunosuppression and response, a meta-analysis.

scientific article published in September 2012

Anxiety and Psychological Stress in Acute Severe Ulcerative Colitis: Prevalence and Effect on Outcome

scholarly article published in May 2011

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases

scientific article published on 27 March 2019

Appropriateness of Combination Therapy in Inflammatory Bowel Disease: One Size Still Does Not Fit All.

scientific article published on 2 March 2018

Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results

scientific article published on 14 May 2016

Are we using and monitoring thiopurines and biologics optimally?

scientific article published on 23 June 2014

Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis

scientific article published on 29 October 2015

Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease

scientific article published on 01 February 2019

Benefits of breath hydrogen testing after lactulose administration in analysing carbohydrate malabsorption.

scientific article published in March 2010

Biologic therapies for Crohn's disease: optimising the old and maximising the new

scientific article published on 29 July 2019

Biologics for inflammatory bowel diseases in the Asia-Pacific: can we afford to use them, can we afford not to?

scientific article published on 01 July 2009

Biosimilars: what's around the corner?

scientific article published on 20 July 2015

British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis

scientific article published on 01 July 2020

British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic

scientific article published on 17 April 2020

CHANGING THERAPY TO ACHIEVE ENDOSCOPIC HEALING IN ASYMPTOMATIC PATIENTS WITH IBD: WHEN IS PERFECT THE ENEMY OF GOOD?

scholarly article

COVID-19 and IBD drugs: should we change anything at the moment?

scientific article published on 19 November 2020

Can We Predict the Toxicity and Response to Thiopurines in Inflammatory Bowel Diseases?

scientific article published on 28 November 2019

Can we get more from our current treatments?

scientific article

Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.

scientific article published on 29 November 2015

Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease

scientific article published on 07 July 2020

Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome

scientific article published on 14 April 2015

Clinical features and genetic risk of demyelination following anti-TNF treatment

scientific article published on 04 June 2020

Clinical trials (and tribulations): the immediate effects of COVID-19 on IBD clinical research activity in the United Kingdom

scientific article published on 29 June 2020

Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease

scientific article published in September 2010

Colonoscopy completion rates: technologies have evolved

scientific article published on November 2004

Common infections, mental health problems and healthcare use in people with inflammatory bowel disease: a cohort study protocol

scientific article published on 17 September 2020

Comparison between assays used for therapeutic drug monitoring of infliximab and adalimumab in inflammatory bowel disease

scientific article published on 05 March 2020

Comparison of Different Strategies for Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile Infection in Two English Hospitals: A Review

scientific article published on 15 February 2018

Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome.

scientific article

Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders

scientific article

Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease

scientific article published on 14 September 2023

Correction of Defective T-Regulatory Cells From Patients With Crohn's Disease by Ex Vivo Ligation of Retinoic Acid Receptor-α

scientific article published on 30 January 2019

Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

scientific article published on 02 June 2020

Cost Analysis of Screening According to ECCO Guidelines for Prevention of Opportunistic Infections in Infliximab-Treated IBD Patients

scholarly article published in May 2011

Cost-effectiveness of biological treatment sequences for fistulising Crohn's disease across Europe.

scientific article published on 8 May 2017

Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group

scientific article

Current Practices in Ileal Pouch Surveillance for Patients With Ulcerative Colitis: A Multinational, Retrospective Cohort Study.

scientific article published in May 2019

Cutting Edge: Regulator of G protein signaling-1 selectively regulates gut T cell trafficking and colitic potential

scientific article

DOP011 A genome wide association study identifying association of the MHC region with 5-aminosalicylate (5-ASA) induced nephrotoxicity in inflammatory bowel disease

scientific article

Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease

scientific article

Development and validation of metric-based-training to proficiency simulation curriculum for upper gastrointestinal endoscopy using a novel assessment checklist

scientific article published on 21 July 2020

De‐escalating medical therapy in Crohn’s disease patients who are in deep remission: A RAND appropriateness panel

scholarly article

Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.

scientific article published on 15 June 2017

Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon

scientific article

Distinct management issues with Crohn's disease of the small intestine

scientific article

Diverticular disease of the colon

scientific article published on 01 April 2004

Drug interactions in inflammatory bowel disease.

scientific article published on 11 December 2007

ECCO IBD Curriculum

Editorial: different tests for different drugs in Crohn's disease, or different tests for different people? Authors' reply.

scientific article published in August 2017

Editorial: establishing a joint approach to a common problem for gastroenterologists

scientific article published on 01 January 2020

Education and imaging. Gastrointestinal: Rapunzel syndrome

scientific article published on 01 December 2007

Effectiveness and safety of vedolizumab in inflammatory bowel disease patients aged 60 and over: an observational multicenter UK experience

scientific article published on 07 January 2020

Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal response

scientific article published on 11 July 2019

Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled Trials

scientific article published on 30 June 2015

Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial

scientific article published on 02 October 2019

Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments

scientific article published on 13 September 2016

Excellent Interobserver Agreement Between a Web-Based Self-Report Questionnaire and Medical Chart Review for the Management of Inflammatory Bowel Disease ⬇️

scholarly article

Factors associated with nonadherence to thiopurines in adolescent and adult patients with inflammatory bowel disease

scientific article published on 01 May 2012

Factors associated with thiopurine non-adherence in patients with inflammatory bowel disease

scientific article published on 15 September 2013

Faecal microbiota transplantation for refractory C lostridium difficile infection

scientific article published on 27 November 2019

Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease.

scientific article published on 23 February 2016

Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome.

scientific article

Fermentable carbohydrates (FODMAPs) exacerbate functional gastrointestinal symptoms in patients with inflammatory bowel disease: a randomised, double-blind, placebo-controlled, cross-over, re-challenge trial

scientific article published on 19 May 2017

Formation of platelet-leukocyte aggregates in inflammatory bowel disease

scientific article published in July 2004

Fructan content of commonly consumed wheat, rye and gluten-free breads.

scientific article published on 23 March 2011

Gastrointestinal toxicity of immune checkpoint inhibitors: from mechanisms to management.

scientific article published on 7 March 2018

Genetic and Inflammatory Biomarkers Classify Small Intestine Inflammation in Asymptomatic First-degree Relatives of Patients With Crohn's Disease

scientific article published on 14 June 2019

Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial

scientific article

Golimumab in the treatment of ulcerative colitis

scholarly article by Georgina Cunningham et al published 2019 in Therapeutic Advances in Gastroenterology

Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact in ulcerative Colitis).

scientific article published on 7 July 2018

Golimumab: early experience and medium-term outcomes from two UK tertiary IBD centres

scientific article published on 11 October 2017

Gut microbiota associations with diet in irritable bowel syndrome and the effect of low FODMAP diet and probiotics

scientific article published on 23 October 2020

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease

scientific article published on 07 October 2019

HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants.

scientific article published on 14 September 2014

Hair loss in patients with inflammatory bowel disease

scientific article published on July 2013

Hidradenitis suppurativa: MRI features in anogenital disease.

scientific article published on June 2014

How should immunomodulators be optimized when used as combination therapy with anti-tumor necrosis factor agents in the management of inflammatory bowel disease?

scientific article

IBD2020 global forum: results of an international patient survey on quality of care

scientific article published on 10 October 2018

Improving quality of care in inflammatory bowel disease: what changes can be made today?

scientific article

Incorporating patient experience into drug development for ulcerative colitis: development of the Urgency Numeric Rating Scale, a patient-reported outcome measure to assess bowel urgency in adults

scientific article published in 2022

Infections and IBD.

scientific article published on January 2008

Inflammatory bowel disease in pregnancy: management strategy based on best evidence and European guidelines

scientific article

Infliximab and Adalimumab Concentrations May Vary Between the Enzyme-Linked Immunosorbent Assay and the Homogeneous Mobility Shift Assay in Patients With Inflammatory Bowel Disease: A Prospective Cross-Sectional Observational Study

scientific article published on 01 October 2019

Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors.

scientific article published on 8 May 2017

Infliximab: getting the most for your money

scientific article published on 01 October 2007

Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation.

scientific article

Interpretation of Anti-TNF Drug Concentration and Antibody Levels in IBD: A Mobile App to Guide Management Based on Results From a RAND Appropriateness Panel ⬇️

scholarly article

Letter: immune checkpoint inhibitor-induced colitis-shouldn't we be checking more often?

scientific article published on 01 August 2019

Leukocytapheresis in ulcerative colitis

scientific article published on 01 January 2006

Long term outcomes of initial infliximab therapy for inflammatory pouch pathology: a multi-Centre retrospective study

scientific article published on 29 September 2018

Long-term impact of the low-FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome.

scientific article published on 14 July 2017

Low FODMAP diet & prebiotic β-galactooligosaccharides improve irritable bowel syndrome and response to low FODMAP is predicted by urine and faecal metabolites: a randomised controlled trial ⬇️

scholarly article

Management of distal ulcerative colitis: frequently asked questions analysis.

scientific article published on February 2008

Managing an IBD Infusion Unit During the COVID-19 Pandemic: Service Modifications and the Patient Perspective

scientific article published on 27 June 2020

Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome

scientific article

Mechanism of allopurinol induced TPMT inhibition

scientific article published on 14 June 2013

Mechanisms and efficacy of dietary FODMAP restriction in IBS.

scientific article

Mo1917 – Ustekinumab: Early Experience and Medium-Term Outcomes from a Uk Multi-Centre Real-World Cohort

scholarly article

NETWORK META-ANALYSIS TO EVALUATE THE COMPARATIVE EFFICACY OF BIOLOGICS FOR MAINTENANCE TREATMENT OF ADULT PATIENTS WITH CROHN’S DISEASE

scholarly article

New role for azathioprine in case of switching anti-TNFs in IBD

scientific article published on 19 February 2020

Nutrient Intake, Diet Quality, and Diet Diversity in Irritable Bowel Syndrome and the Impact of the Low FODMAP Diet

scientific article published on 24 April 2019

Observational Study of Perspectives of Inflammatory Bowel Disease Patients Concerning the Use of Corticosteroids

scientific article published on 2 September 2017

Oesophageal Crohn's disease: a novel approach to managing iatrogenic perforation of an oesophageal Crohn's stricture.

scientific article published on 20 November 2013

Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol

scientific article published on 3 March 2012

Optimising use of thiopurines in inflammatory bowel disease

scientific article

Optimization of conventional therapy in patients with IBD.

scientific article published on 04 October 2011

Optimizing conventional therapies for inflammatory bowel disease

scientific article published on December 2009

Optimizing quality of outpatient care for patients with inflammatory bowel disease: the importance of specialist clinics

scientific article published in March 2006

Oral Anti-Tumour Necrosis Factor Domain Antibody V565 Provides High Intestinal Concentrations, and Reduces Markers of Inflammation in Ulcerative Colitis Patients

scientific article published on 01 October 2019

Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemic

scientific article published on 16 June 2020

P126 The Urgency Numeric Rating Scale (NRS): a novel patient-reported outcome measure to assess bowel urgency in adult patients with ulcerative colitis ⬇️

scholarly article

P193 Validation of the two-item UC patient-reported outcome (PRO2) against the simple clinical colitis activity index (SCCAI), measures of biochemical disease activity and quality of life ⬇️

scholarly article

P485 Switching infliximab biosimilar: No adverse impact on inflammatory bowel disease control or drug levels with the first or second switch ⬇️

scholarly article

P706 Adalimumab drug levels at secondary loss of response in Crohn’s disease; are we aiming high enough? A retrospective, international multi-centre study ⬇️

scholarly article

Patient optimization for surgery relating to Crohn's disease

scientific article

Percutaneous endoscopic gastrostomy with a jejunal port for severe hyperemesis gravidarum

scientific article published in September 2004

Platelet-leucocyte aggregates form in the mesenteric vasculature in patients with ulcerative colitis

scientific article published on 01 April 2008

Positioning Treatments for Ulcerative Colitis: A RAND Appropriateness Panel ⬇️

scholarly article

Positioning biologics and new therapies in the management of inflammatory bowel disease

scientific article published on 22 April 2019

Poster presentations at medical conferences: an effective way of disseminating research?

scientific article published in April 2011

Prebiotic β-galacto-oligosaccharide impact on clinical, inflammatory and microbiota outcomes in active ulcerative colitis: an open-label study ⬇️

scholarly article

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

scientific article published on 27 February 2019

Prevalence and Risk Factors for Functional Vitamin B12 Deficiency in Patients with Crohn's Disease

scientific article published on 19 August 2015

Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome ⬇️

scientific article

Prophylactic gastrostomy for head & neck cancer: 5 year experience from a tertiary referral centre

scientific article published on 28 August 2015

Quality, clinical influence and tolerance of computed tomography enteroclysis in patients with suspected small bowel disease

scientific article published on 11 November 2008

Real-World Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multi-Centre UK Experience

scientific article published on 13 April 2020

Reassessment of Crohn's disease treated with at least 12 months of anti-TNF therapy: how likely is treatment withdrawal?

scientific article published on 24 December 2013

Recent advances in monoclonal antibody therapy in IBD: practical issues

scientific article published on 18 January 2019

Recent advances in the management of inflammatory bowel disease.

scientific article published on December 2009

Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel.

scientific article published on 6 April 2016

Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study.

scientific article

Regulatory T-cell therapy in Crohn's disease: challenges and advances

scientific article published on 24 January 2020

Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis.

scientific article published on 19 February 2016

Review article: appropriate use of corticosteroids in Crohn's disease.

scientific article published on August 2007

Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease

scientific article published on 16 April 2010

Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study

scientific article published on 01 September 2020

Semiquantitative assessment of breath hydrogen testing

scientific article published in September 2013

Setting priorities for comparative effectiveness research in inflammatory bowel disease: results of an international provider survey, expert RAND panel, and patient focus groups.

scientific article published on 15 February 2012

Small bowel MR enterography: problem solving in Crohn's disease

scientific article published on 17 March 2012

Steroids in villous atrophy: opening a can of worms?

scientific article

Successful faecal microbiota transplant for recurrent Clostridium difficile infection delivered by colonoscopy through a diverted ileostomy in a patient with severe perianal Crohn's disease.

scientific article published on 5 March 2018

The Clinical and Cost-Effectiveness of 4 Enzyme-Linked Immunosorbent Assay Kits for Monitoring Infliximab in Crohn Disease Patients: Protocol for a Validation Study

scientific article published on 19 October 2018

The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

scientific article published on 01 February 2020

The Glasgow Blatchford scoring system enables accurate risk stratification of patients with upper gastrointestinal haemorrhage

scientific article published on 10 March 2010

The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all.

scientific article published on 06 May 2010

The challenges of control groups, placebos and blinding in clinical trials of dietary interventions

scientific article

The challenges of control groups, placebos and blinding in clinical trials of dietary interventions

scientific article published on 31 August 2017

The effects of COVID-19 on IBD prescribing and service provision in a UK tertiary centre

scientific article published on 01 November 2020

The future developments in inflammatory bowel disease care

scientific article published on 31 May 2012

The impact of introducing thioguanine nucleotide monitoring into an inflammatory bowel disease clinic

scientific article published on 17 December 2012

The impact of updated NICE guidelines on biologic treatment of ulcerative colitis: reflections on past practices, the changing present and implications for the future

scientific article published on 17 May 2016

The γδTCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness

scientific article published on 12 November 2018

Therapeutic thresholds for golimumab serum concentrations during induction and maintenance therapy in ulcerative colitis: results from the GO-LEVEL study

scientific article published on 07 June 2020

Thioguanine in inflammatory bowel disease: Long-term efficacy and safety

scientific article

Thiopurine methyltransferase and thiopurine metabolite testing in patients with inflammatory bowel disease who are taking thiopurine drugs.

scientific article published in July 2009

Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients

scientific article

Thiopurines Dosed to a Therapeutic 6-Thioguanine Level in Combination with Adalimumab Are More Effective Than Subtherapeutic Thiopurine-based Combination Therapy or Adalimumab Monotherapy During Induction and Maintenance in Patients with Long-standi

scientific article published on 3 August 2017

Thrombosis and inflammatory bowel disease

scientific article

Tofacitinib for the Treatment of Ulcerative Colitis, Alopecia Universalis, and Atopic Dermatitis: One Drug, Three Diseases

scientific article published on 18 September 2020

Tofacitinib in Acute Severe Ulcerative Colitis-A Real-World Tertiary Center Experience

scientific article published on 22 June 2020

Toxicity and response to thiopurines in patients with inflammatory bowel disease

scientific article published on 27 April 2015

Tu1811 - Colonic Gamma Delta T Cells Respond Innately to Nkg2D Ligands and are Grossly Dysregulated in Active Inflammatory Bowel Disease

scholarly article published in May 2018

Tu1830 – Infliximab and Adalimumab Concentrations May Vary Between the Enzyme-Linked Immunosorbent Assay and the Homogeneous Mobility Shift Assay in Patients with Inflammatory Bowel Disease

scholarly article

Type C mucosa in pouch surveillance: make, do and mend rather than start from scratch?

scientific article published on 10 March 2020

Use of azathioprine in IBD: modern aspects of an old drug

scientific article published on 18 June 2014

Utilisation of anti-TNF levels in a UK tertiary IBD centre.

scientific article published on 29 November 2016

Validation and Investigation of the Operating Characteristics of the Ulcerative Colitis Endoscopic Index of Severity

scientific article published on 01 April 2019

Vedolizumab Dose Escalation: In for a Penny, in for a Pound?

scientific article published on 24 August 2020

Vedolizumab in Inflammatory Bowel Disease Associated with Autoimmune Liver Disease Pre- and Postliver Transplantation: A Case Series

scientific article published on 01 October 2016

Vedolizumab-Associated Drug-Induced Liver Injury: A Case Series

scientific article published on 06 November 2020

Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centres.

scientific article published on 10 August 2016

Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis.

scientific article published on 03 March 2017

Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel Syndrome

scientific article published on 6 October 2017

What changes in inflammatory bowel disease management can be implemented today?

scientific article published on February 2012

Wide variation in the use and understanding of therapeutic drug monitoring for anti-TNF agents in inflammatory bowel disease: an inexact science?

scientific article published on 24 October 2018

αEβ7 Integrin Identifies Subsets of Pro-Inflammatory Colonic CD4+ T Lymphocytes in Ulcerative Colitis

scientific article published on May 2017

β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria

scientific article published on 20 May 2020

Paulina is supported by:

About Paulina

Help